Onderneming Micromedic Technologies Ltd TEL AVIV STOCK EXCHANGE
Aandelen
IL0004330119
Biotechnologie & Medisch Onderzoek
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Abraham Dreazen
CEO | Chief Executive Officer | 40 | 12-08-20 |
Ishai Gandelsman
DFI | Director of Finance/CFO | 61 | 10-07-22 |
General Counsel | 53 | 12-08-20 | |
Daniel Spira
AUD | Comptroller/Controller/Auditor | 69 | 01-01-94 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Yaacov Elinav
BRD | Director/Board Member | 79 | 12-08-20 |
Israel Makov
CHM | Chairman | 85 | 21-11-11 |
Ron Grupel
BRD | Director/Board Member | 73 | 13-10-14 |
Jakob Ripshtein
BRD | Director/Board Member | 57 | 12-08-20 |
Orna Dreazen
BRD | Director/Board Member | 69 | 12-08-20 |
Director/Board Member | 59 | 12-08-20 | |
Director/Board Member | 72 | 12-08-20 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 32 601 972 | 5 226 508 ( 16,03 %) | 0 | 16,03 % |
Bedrijfsgegevens
NEXTAGE Therapeutics Ltd.
Einstein Street, Building 13B Weizmann Science Park
7403617, Ness Ziona
+
http://www.nxtg.co.ilSector
Vaira. 1 jan. | Kapi. | |
---|---|---|
-32,63% | 9,2 mld. | |
-5,66% | 3,12 mld. | |
+23,12% | 2,8 mld. | |
-18,33% | 2,05 mld. | |
-24,39% | 1,59 mld. | |
+65,65% | 1,44 mld. | |
+32,83% | 830 mln. | |
-6,77% | 720 mln. | |
-29,80% | 507 mln. |